---
figid: PMC7586431__ijbsv16p2704g005
figlink: pmc/articles/PMC7586431/figure/F5/
number: F5
caption: Statin therapy for cancer. When statins enter cells and block HMG-CoA reductase
  activity, the mevalonate pathway end product, RhoA is depleted. Depression of RhoA
  can affect the stability of the cytoskeleton, further prevent the YAP entering cell
  nucleus, here, YAP will drive transcription of target genes with TEAD to promote
  the tumor tissue growth. At the same time, KRAS is another important downstream
  molecule in the mevalonate pathway, which can activate the MAPK signal to accelerate
  cell proliferation, thus restraining KRAS will delay cancer cell proliferation.
  In addition to the mevalonate pathway, statins could directly depress the AKT signal,
  effect the synthesis and degradation p21 and p27, at last block the cell cycle progression.
  Besides, statin can activate caspase-8, caspase-3 and caspase-9 to induce apoptosis,
  and suppress angiogenesis by inhibiting TNF-α.
pmcid: PMC7586431
papertitle: Pleiotropic use of Statins as non-lipid-lowering drugs.
reftext: Qijia Zhang, et al. Int J Biol Sci. 2020;16(14):2704-2711.
pmc_ranked_result_index: '2525'
pathway_score: 0.9381966
filename: ijbsv16p2704g005.jpg
figtitle: Statin therapy for cancer
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7586431__ijbsv16p2704g005.html
  '@type': Dataset
  description: Statin therapy for cancer. When statins enter cells and block HMG-CoA
    reductase activity, the mevalonate pathway end product, RhoA is depleted. Depression
    of RhoA can affect the stability of the cytoskeleton, further prevent the YAP
    entering cell nucleus, here, YAP will drive transcription of target genes with
    TEAD to promote the tumor tissue growth. At the same time, KRAS is another important
    downstream molecule in the mevalonate pathway, which can activate the MAPK signal
    to accelerate cell proliferation, thus restraining KRAS will delay cancer cell
    proliferation. In addition to the mevalonate pathway, statins could directly depress
    the AKT signal, effect the synthesis and degradation p21 and p27, at last block
    the cell cycle progression. Besides, statin can activate caspase-8, caspase-3
    and caspase-9 to induce apoptosis, and suppress angiogenesis by inhibiting TNF-α.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP9
  - TNF
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - KRAS
  - EIF4EBP1
  - RHOA
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - YY1AP1
  - TF
  - EIF4E
  - statins
  - FPP
  - Cancer
genes:
- word: CASP-3/8/9
  symbol: CASP9
  source: hgnc_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: elF-4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
chemicals:
- word: statins
  source: MESH
  identifier: D019821
- word: FPP
  source: MESH
  identifier: C039834
diseases:
- word: Cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7586431__F5
redirect_from: /figures/PMC7586431__F5
figtype: Figure
---
